Investing in Oxygen Access: A Lifeline for Health Resilience in Asia

Medical oxygen is vital for universal health coverage and pandemic preparedness across Asia. Photo credit: ADB.

Share on:           

Published:

Health systems must prioritize sustainable oxygen supply to strengthen routine care and prepare for future pandemics.

Introduction

Access to medical oxygen remains one of the most underfunded but essential components of resilient health systems. In Asia—where the largest number of patients with unmet oxygen needs reside—there is an urgent need for greater government investment in oxygen systems to advance long-term health reforms while ensuring pandemic preparedness.

A Lancet Global Health report estimates that 374 million people globally require oxygen every year, and more than half of them—181 million—are in Asia. Yet only one in four patients in the region who require medical oxygen actually receive it.

Oxygen was one of the main topics during the Asian Development Bank’s (ADB) 1st INSPIRE Health Forum: Inclusive, Sustainable, Prosperous and Resilient (INSPIRE) Health Systems in Asia and the Pacific. The discussions centered on how countries can strengthen their health systems to ensure oxygen access, emphasizing that oxygen should not be viewed merely as an emergency commodity, but as a strategic investment that addresses two priorities simultaneously: saving lives today and preparing health systems for future pandemics.

Embedding Oxygen into National Health Strategies

During the COVID-19 pandemic, access to oxygen made the difference between recovery or death for countless patients. Investments made during COVID-19, through The Global Fund and many others, continue to deliver benefits today in over 100 countries. But despite more than $1 billion in COVID-19 oxygen support, wide gaps in access to oxygen persist.

Closing the global oxygen gap by 2030 will require about $4.4 billion in annual investment. While this figure is large, the impact is transformative as oxygen treats multiple conditions, including newborn complications, pneumonia, tuberculosis, HIV, malaria, chronic respiratory disease, and more. It is also essential for safe surgery.

The Global Oxygen Strategic Framework and Investment Case, commissioned and codeveloped by the Global Oxygen Alliance (GO₂AL), noted that meeting the additional investment needed could save 860,000 lives across the world by 2030, including 331,000 children under five.

Countries are already moving from crisis response to long-term planning to maintain the COVID-19 oxygen supplies and ensure universal access to medical oxygen in their health systems. Examples from Armenia, the Cook Islands, and Fiji were discussed at the ADB INSPIRE Forum:

  • Armenia now requires hospitals to have oxygen supply as a condition of licensing.
  • In the Cook Islands, a new pressure swing adsorption oxygen generation plant donated during the pandemic was initially placed in a less suitable locale but has since been relocated to Rarotonga, where it now serves as the main hub for oxygen production and distribution to the sister islands.
  • Fiji has committed to sustaining the Fiji Oxygen Project, a successful donor-supported initiative that installed solar-powered mobile oxygen concentrators in Fiji hospitals.

Development partners are also strengthening support, such as:

  • Japan invested in expanding oxygen access in low-resource settings, including establishing the East African Program on Oxygen Access, a partnership with the governments of Kenya and Tanzania, Unitaid, and the Clinton Health Access Initiative to establish the first Africa-owned liquid oxygen production plant that will increase both medical oxygen supply and lower prices for hospitals across East Africa.
  • The Pandemic Fund has awarded $885 million in grants to 75 countries to strengthen system resilience, with more support planned where medical oxygen will hopefully be in scope.
  • GO₂AL is supporting countries to develop costed national oxygen plans that cover both capital and operational costs so that donors can invest.

Results from an ADB Capital Health Assets Management Platform 2024 survey underscore that infrastructure alone is not enough. Of 80 health facilities in Nepal, it found that mobile oxygen concentrators accounted for 35% of all uninstalled medical equipment donated during the pandemic. The reason was not lack of demand, but a shortage of biomedical engineers and technicians to install and maintain the machines. This demonstrates that without investments in human capital, vital equipment risks sitting idle.

Governments across Asia are acting on the lessons of COVID-19. Many are beginning to integrate oxygen into health strategies, recognizing it as a vital resource for both everyday care and emergency preparedness. At the same time, GO₂AL members are working with countries to strengthen financing, planning, and workforce development.

Turning Lessons into Lasting Reforms

Lessons from the pandemic across Asia are informing smart strategies to strengthen national medical oxygen systems, including to:

Integrate oxygen into broader health reforms. Oxygen should not be managed as a temporary or vertical intervention. Embedding it into health financing frameworks, facility licensing requirements, and national universal health care strategies ensure access, affordability, and resilience, including during emergencies.

Prioritize sustainability. Donations during COVID-19 were lifesaving but may be unsustainable. Moving forward, financing mechanisms must include budget, maintenance, and workforce training to prevent equipment from sitting idle.

Strengthen cross-sector partnerships. Oxygen systems depend on energy, infrastructure, transportation, education, and supply chains, not just the health sector. Coordinated investment across ministries and with development partners can maximize reach and efficiency.

Invest in both people and systems. The shortage of biomedical engineers and technicians illustrates that resilient oxygen access requires trained human resources alongside infrastructure. Long-term capacity-building should be a central element of national oxygen strategies.

With Asia facing the greatest burden of premature and pandemic-related deaths, and projections pointing to a high probability of another pandemic within 25 years, there is limited time to translate lessons from COVID-19 into durable reforms.

Institutions such as ADB can play a convening and financing role, helping governments mobilize resources, align partners, and share lessons. Partnerships built around oxygen can serve as a model for other critical areas of health system strengthening.

Note: Examples cited regarding Armenia, the Cook Islands, and Fiji were taken from presentations by Armenia Ministry of Health First Deputy Lena Nanushyan, Cook Islands Health Minister Hon. Vainetutai Rose Toki-Brown, and Fiji Health and Medical Services Hon. Minister Dr. Ratu Atonio Rabici Lalabalavu.

Insights were also taken from the presentations of Priya Basu (The Pandemic Fund Executive Head) and Amanda McClelland (Resolve to Save Lives Senior Vice President, Prevent Epidemics). Ben Coghlan (ADB) and Elena Pantjushenko (PATH) prepared the article. 

Vainetutai Rose Toki-Brown
Minister of Health, Cook Islands

Aside from her role as Health Minister, Honourable Vainetutai Rose Toki-Brown is also responsible for the country's agriculture, national superannuation, and internal affairs.

Hamish Graham
Associate Professor of International Child Health, University of Melbourne, Australia

Dr. Hamish Graham is an experienced global health researcher and practitioner with skills in public health, management, and pediatric clinical care. He is driven to bring life-giving health interventions to children around the world.

Follow Hamish Graham on

Peter Sands
Executive Director, The Global Fund

Peter Sands is responsible for the overall leadership and management of the Global Fund’s operational and administrative functions. He defines the partnership’s strategic vision and is accountable for its implementation and achievements.

Follow Peter Sands on

Yosuke Kita
Director, Global Health Strategy Division, Ministry of Foreign Affairs of Japan (MOFA)

Dr. Yosuke Kita has over a decade of experience in public and global health. Before joining MOFA, he was senior coordinator for Global Health at Japan’s Ministry of Health, Labour and Welfare, where he led the COVID-19 response on the Diamond Princess cruise ship. He was also Counsellor at Japan’s Permanent Mission to the United Nations, where he negotiated health agendas such as universal health coverage and pandemic preparedness, and facilitated discussions on population issues as Vice-Chair of the 57th UN Commission on Population and Development.

Follow Yosuke Kita on

Ayako Inagaki
Senior Director, Human and Social Development Sector Office, Sector Department 3, Asian Development Bank

Ayako Inagaki leads the Human and Social Development Sector Office, overseeing financial and technical assistance operations and knowledge services in education, health, and social development across ADB’s developing member countries. She has led lending and non-lending operations in Southeast and South Asia and brings over 30 years of sector experience. Her recent focus includes emerging and cross-cutting issues in human and social development, such as post-COVID-19 recovery, digital transformation, and climate change.

Robert Matiru
Director (Programme Division), Unitaid

Robert Matiru leads a $1.3 billion innovation portfolio advancing access to health products for HIV/AIDS, tuberculosis, malaria, cervical cancer, and maternal and child health. With 20 years in international development, he is recognized for building high-performing teams, mobilizing resources, and forging strategic partnerships to accelerate health innovations. His expertise spans global health financing, portfolio management, and policy engagement, with previous leadership roles at WHO’s H1N1 Pandemic Response and the Global TB Drug Facility.

Follow Robert Matiru on

Asian Development Bank (ADB)

The Asian Development Bank is a leading multilateral development bank supporting sustainable, inclusive, and resilient growth across Asia and the Pacific. Working with its members and partners to solve complex challenges together, ADB harnesses innovative financial tools and strategic partnerships to transform lives, build quality infrastructure, and safeguard our planet. Founded in 1966, ADB is owned by 69 members—49 from the region.

Follow Asian Development Bank (ADB) on
Leave your question or comment in the section below:
Disclaimer

The views expressed on this website are those of the authors and do not necessarily reflect the views and policies of the Asian Development Bank (ADB) or its Board of Governors or the governments they represent. ADB does not guarantee the accuracy of the data included in this publication and accepts no responsibility for any consequence of their use. By making any designation of or reference to a particular territory or geographic area, or by using the term “country” in this document, ADB does not intend to make any judgments as to the legal or other status of any territory or area.